Another vaccine hiccup

You’d think so logically wouldn’t you BlueSky.
I was interested in volunteering for new combination vaccine trials but unfortunately not in eligible postcode. I think they are using Moderna and Novavax in addition to Pfizer and AZ.

I would have thought these adenovirus type of vaccines would have been the most trouble free as they use a process already tried and tested, while the ones with mRNA are new technology. Instead they seem to be the ones with more teething problems.

I wonder who’s carrying the liability in the States for J and J? I don’t know which route the FDA went down.

6 cases ( all female between age 18-48) in more than 7 million people vaccinated with this vaccine, so very rare. Wise for them to pause and review the data.

It’s a similar type of vaccine to the the Astra Zeneca vaccine, ie based on the adenovirus, so I guess this isn’t unexpected. I read that they’d vaccinated 7 million in US with it prior to putting it on hold, and the number of rare type blood clots were very few.

Sorry I meant Europe. I know USA are doing ok but would do better without delays.

They aren’t at all AGAA4, they have vaccinated only 2% less of their population than the UK, 57%, so are doing really well in the USA. according to Our World in Data - I’m glad to say. Other countries are making real headway now too, including some in Europe. It’s an improving picture.

It will delay the roll out as it did in Europe. They are a way behind the UK now.

It was initially branded to be one of the more efficient vaccines with only one shot needed and storage in an ordinary 'fridge as opposed to a freezer like the others.